Provided by Tiger Trade Technology Pte. Ltd.

IT Tech Packaging Inc

0.1740
-0.0051-2.85%
Volume:21.35K
Turnover:3.72K
Market Cap:2.95M
PE:-0.20
High:0.1791
Open:0.1730
Low:0.1728
Close:0.1791
52wk High:0.3900
52wk Low:0.1600
Shares:16.97M
Float Shares:16.42M
Volume Ratio:0.19
T/O Rate:0.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8619
EPS(LYR):-0.9779
ROE:-6.92%
ROA:-3.36%
PB:0.02
PE(LYR):-0.18

Loading ...

Press Release: InnoCare Reports 2026 Interim Results, Sustained Profitability and Key Milestones Achieved

Dow Jones
·
Yesterday

Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

GlobeNewswire
·
Yesterday

It Tech Packaging Tunda Rilis Laporan Keuangan Kuartal II 2026, Ajukan Pemberitahuan Keterlambatan 10-Q

Reuters
·
Aug 12

Press Release: Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results

Dow Jones
·
Aug 06

Agios Reports Second Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire
·
Jul 30

Grifols Doses First Patients in Two Phase 3 Trials to Expand Indications of its Flagship Immunoglobulins

GlobeNewswire
·
Jul 16

Press Release: Bionano Announces Hiring of Chief Scientific Officer

Dow Jones
·
Jun 24

Bionano Announces Multiple Publications in 2026 Describing Unique Utility of OGM in Studies of Reproductive Health and Prenatal Genetic Disorders

GlobeNewswire
·
Jun 11

Climb Bio Reports Encouraging Early Budoprutug ITP Data

TIPRANKS
·
Jun 11

Climb Bio Announces Initial Phase 1b Data Demonstrating On-Target Clinical Activity for Budoprutug in Immune Thrombocytopenia at EHA Congress 2026

GlobeNewswire
·
Jun 11

Cullinan Therapeutics Shares New Clinical Data Across Its Portfolio of T Cell Engager Programs Targeting CD19 and BCMA in Autoimmune Diseases

GlobeNewswire
·
Jun 10

argenx Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit in Myositis and Sjogren’s Disease at EULAR 2026

GlobeNewswire
·
Jun 03

Agios Enters Exclusive Global License Agreement with Oscotec to Develop and Commercialize Next-Generation SYK Inhibitor Cevidoplenib

GlobeNewswire
·
Jun 01

InnoCare Pharma Gets Acceptance for ITP New Drug Application; Shares Up 3%

MT Newswires Live
·
May 29

Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures

GlobeNewswire
·
May 28

InnoCare’s ITP Drug Filing for Orelabrutinib Accepted by China Regulator

TIPRANKS
·
May 28

Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia

GlobeNewswire
·
May 26

Climb Bio to Present on CLYM116 and Budoprutug Programs at European Renal Association (ERA) Congress 2026

GlobeNewswire
·
May 26

US$800 million commitment achieved by FAST-P initiative Green Investments Partnership

Lin Daoyi
·
May 20

Climb Bio to Present New Budoprutug Clinical Data at European Hematology Association (EHA) 2026 Congress

GlobeNewswire
·
May 14